Full name
BERLIN-CHEMIE / MENARINI POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
73.11.Z - Advertising agencies activities
82.92.Z - Packaging activities
85.59.B - Other out-of-school forms of education, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 33,4 | 36,2 | 49,5 | 36,8 |
EBITDA | 34,9 | 37,5 | 50,1 | 33,7 |
Short time liabilities | 84,2 | 79,3 | 124,2 | 56,7 |
Equity capital | 115 | 143,1 | 182 | 27,1 |
Operating profit (EBIT) | 33,8 | 36,3 | 49 | 35 |
Assets | 214,2 | 238,3 | 324,4 | 36,1 |
Net profit (loss) | 26,2 | 28,1 | 38,8 | 38 |
Cash | 0,5 | 0,6 | 0,7 | 17,5 |
Net income from sale | 682,5 | 754,6 | 867,7 | 15 |
Liabilities and provisions for liabilities | 99,3 | 95,2 | 142,4 | 49,7 |
Working assets | 205,8 | 229,9 | 313,6 | 36,4 |
Depreciation | 1,1 | 1,2 | 1,1 | -6,2 |
% | % | % | p.p. | |
Profitability of capital | 22,8 | 19,7 | 21,3 | 1,6 |
Equity capital to total assets | 53,7 | 60,1 | 56,1 | -4 |
Gross profit margin | 4,9 | 4,8 | 5,7 | 0,9 |
EBITDA Margin | 5,1 | 5 | 5,8 | 0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 45 | 38 | 52 | 14 |
Current financial liquidity indicator | 2.457108497619629 | 2.2346420288085938 | -0,3 | |
Net dept to EBITDA | -0.016398077830672264 | 0.31492701172828674 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane